Le produit a bien été ajouté au panier.

discount label
H-ILSPFLPL-OH
Vue en 3D

Biosynth logo

H-ILSPFLPL-OH

Ref. 3D-PP49878

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-ILSPFLPL-OH
Description :

Peptide H-ILSPFLPL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ILSPFLPL-OH include the following: Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines Y Wang, Y Guo, X Wang, J Huang - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/186/5/2860/762 The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination X Du, G Zheng, H Jin, Y Kang , J Wang - The Journal of Gene , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jgm.1004 Hemokinin-1 as an adjuvant molecule enhancing humoral and memory responses to HBsAg DNA vaccination X Chen, W Zhang, W Gao, Q Zou , C Feng, H Liu - Viral , 2012 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.2012.0015 Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination W Zhang, X Du, G Zhao, H Jin, Y Kang , C Xiao, M Liu - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09008603 Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine W Xu, Y Chu , R Zhang, H Xu, Y Wang, S Xiong - Virology, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682205000899 Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses S Roh, YK Lee, BY Ahn, K Kim, A Moon - Virus Research, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168170200002197 Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen R Schirmbeck, W Böhm, N Fissolo - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324125 Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants R Schirmbeck, N Dikopoulos, M Kwissa - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324403 Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen R Schirmbeck, K Melber, J Reimann - International immunology, 1999 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/11/7/1093/667756 Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen R Schirmbeck, J Wild, J Reimann - European journal of , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199812)28:12%3C4149::AID-IMMU4149%3E3.0.CO;2-D The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted R Schirmbeck, D Stober, S El Kholy, P Riedl - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/12/6253/33599 Mafosfamide combine with GMI-HBVac against HBV via Treg depletion in HBV-infected mice Q Lin, Y Zhong, B Wang - 2023 - preprints.orghttps://www.preprints.org/manuscript/202303.0085 A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice P Buchmann, C Dembek, L Kuklick, C Jager - Vaccine, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X12018610 Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8+ T cell responses L Cheng, X Du , Z Wang, J Ju, M Jia , Q Huang - Journal of , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168827814004723 Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation J Reimann, R Schirmbeck - Immunological reviews, 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-065X.1999.tb01362.x Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface ES Song, SA Park, SH Kim, YJ Cho - FEMS Immunology & , 2007 - academic.oup.comhttps://academic.oup.com/femspd/article-abstract/51/3/496/631551 Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells D Stober<, Z Trobonjaca , J Reimann - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200204)32:4%3C1099::AID-IMMU1099%3E3.0.CO;2-8 NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo D Stober, I Jomantaitė, R Schirmbeck - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/170/5/2540/71290 Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long"‘lasting and balanced immune responses CH Yu, ZC Luo , M Li, L Lu, Z Li - Molecular , 2016 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/mmr.2015.4581?text=abstract B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses C Wahl, P Bochtler, L Chen , R Schirmbeck, J Reimann - Gastroenterology, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0016508508009517 Modified alphavirus-vesiculovirus hybrid vaccine vectors for homologous prime-boost immunotherapy of chronic hepatitis B C Chiale , TO Yarovinsky, SW Mason, BR Madina - Vaccines, 2020 - mdpi.comhttps://www.mdpi.com/2076-393X/8/2/279 In Vivo Compartmentalization of Functionally Distinct, Rapidly Responsive Antigen-Specific T-Cell Populations in DNA-Immunized or Salmonella enterica Serovar AC Kirby, M Sundquist, MJ Wick - Infection and immunity, 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.72.11.6390-6400.2004 Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody A Baez-Astacaºa, E Herraez-Hernandez, N Garbi - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.20.12807-12817.2005

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP49878 H-ILSPFLPL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".